. . . . . . . "[We treated 20 patients who had recurrent prostate cancer with 200 ?moles/day of sulforaphane-rich extracts for a maximum period of 20 weeks and determined the proportion of patients with ?50% PSA declines, the primary endpoint.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:41+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .